A Comparative Study of KW-2246
by on Thursday, March 31st, 2011 | No Comments
Condition: Cancer Related Pain (Breakthrough Pain)
Intervention: Drug: KW-2246
Sponsor: Kyowa Hakko Kirin Company, Limited
Recruiting – verified March 2011
More here: A Comparative Study of KW-2246